1200.0000 -5.00 (-0.41%)
NSE Apr 24, 2025 15:29 PM
Volume: 269.1K
 

ICICI Securities Limited
Suven’s rapid ascendance in the CDMO space has been remarkable. It has journeyed from being a small molecule-focused CDMO to achieving eminence as one of the few CDMOs in India that offers contract manufacturing of oligonucleotides and ADCs.
Suven Pharmaceuticals Ltd. has gained 85.92% in the last 1 Year
More from Suven Pharmaceuticals Ltd.
Recommended